Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could pregnancy loss signal future cancer risk? new study investigates

NCT ID NCT03969498

First seen Jan 06, 2026 · Last updated Jun 23, 2026 · Updated 29 times

Summary

This study followed over 1,500 women who had pregnancy losses and were tested for antiphospholipid syndrome (APS) and other clotting disorders. Researchers compared cancer rates among women with APS, those with other clotting gene changes, and those with no clotting issues. The goal is to see if having APS or other clotting problems raises the risk of developing cancer later in life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CHUNimes

    Nîmes, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If this study finds a link, it could help identify women with pregnancy loss who may need cancer screening.

What could go wrong

This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all women.

Conditions

The condition(s) this trial relates to.

antiphospholipid syndrome neoplasm pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.